- Home
- AMPG vs PASG Comparison
AMPG vs PASG Comparison
Compare AMPG & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- PASG
- Stock Information
- Founded
- AMPG 2002
- PASG 2017
- Country
- AMPG United States
- PASG United States
- Employees
- AMPG N/A
- PASG N/A
- Industry
- AMPG Telecommunications Equipment
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- AMPG Telecommunications
- PASG Health Care
- Exchange
- AMPG Nasdaq
- PASG Nasdaq
- Market Cap
- AMPG 29.1M
- PASG 31.1M
- IPO Year
- AMPG N/A
- PASG 2020
- Fundamental
- Price
- AMPG $1.50
- PASG $0.39
- Analyst Decision
- AMPG Strong Buy
- PASG Strong Buy
- Analyst Count
- AMPG 1
- PASG 3
- Target Price
- AMPG $5.00
- PASG $7.67
- AVG Volume (30 Days)
- AMPG 260.9K
- PASG 163.1K
- Earning Date
- AMPG 05-27-2025
- PASG 05-13-2025
- Dividend Yield
- AMPG N/A
- PASG N/A
- EPS Growth
- AMPG N/A
- PASG N/A
- EPS
- AMPG N/A
- PASG N/A
- Revenue
- AMPG $9,508,372.00
- PASG N/A
- Revenue This Year
- AMPG N/A
- PASG N/A
- Revenue Next Year
- AMPG $58.88
- PASG N/A
- P/E Ratio
- AMPG N/A
- PASG N/A
- Revenue Growth
- AMPG N/A
- PASG N/A
- 52 Week Low
- AMPG $0.64
- PASG $0.33
- 52 Week High
- AMPG $6.43
- PASG $1.64
- Technical
- Relative Strength Index (RSI)
- AMPG 39.40
- PASG 39.40
- Support Level
- AMPG $1.42
- PASG $0.33
- Resistance Level
- AMPG $1.60
- PASG $0.54
- Average True Range (ATR)
- AMPG 0.14
- PASG 0.05
- MACD
- AMPG -0.00
- PASG -0.00
- Stochastic Oscillator
- AMPG 15.69
- PASG 31.13
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.